Affluent Medical SA (EPA:AFME)

Affluent Medical Statistics

Total Valuation

EPA:AFME has a market cap or net worth of EUR 57.06 million. The enterprise value is 66.76 million.

Market Cap	57.06M
Enterprise Value	66.76M

Important Dates

The next estimated earnings date is Friday, September 26, 2025.

Earnings Date	Sep 26, 2025
Ex-Dividend Date	n/a

Share Statistics

EPA:AFME has 39.35 million shares outstanding.

Current Share Class	39.35M
Shares Outstanding	39.35M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.42%
Owned by Institutions (%)	n/a
Float	10.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.66
PB Ratio	1.88
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.53
EV / Sales	12.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.82

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.54.

Current Ratio	1.28
Quick Ratio	1.06
Debt / Equity	0.54
Debt / EBITDA	n/a
Debt / FCF	-1.42
Interest Coverage	-29.18

Financial Efficiency

Return on equity (ROE) is -47.70% and return on invested capital (ROIC) is -19.22%.

Return on Equity (ROE)	-47.70%
Return on Assets (ROA)	-15.58%
Return on Invested Capital (ROIC)	-19.22%
Return on Capital Employed (ROCE)	-28.54%
Revenue Per Employee	68,590
Profits Per Employee	-188,962
Employee Count	63
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	-142,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.48% in the last 52 weeks. The beta is 0.71, so EPA:AFME's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-24.48%
50-Day Moving Average	1.41
200-Day Moving Average	1.39
Relative Strength Index (RSI)	46.11
Average Volume (20 Days)	13,948

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EPA:AFME had revenue of EUR 5.35 million and -14.74 million in losses. Loss per share was -0.41.

Revenue	5.35M
Gross Profit	1.76M
Operating Income	-14.65M
Pretax Income	-14.88M
Net Income	-14.74M
EBITDA	-12.61M
EBIT	-14.65M
Loss Per Share	-0.41

Balance Sheet

The company has 6.62 million in cash and 16.33 million in debt, giving a net cash position of -9.71 million or -0.25 per share.

Cash & Cash Equivalents	6.62M
Total Debt	16.33M
Net Cash	-9.71M
Net Cash Per Share	-0.25
Equity (Book Value)	30.27M
Book Value Per Share	0.77
Working Capital	2.62M

Cash Flow

In the last 12 months, operating cash flow was -11.32 million and capital expenditures -147,000, giving a free cash flow of -11.47 million.

Operating Cash Flow	-11.32M
Capital Expenditures	-147,000
Free Cash Flow	-11.47M
FCF Per Share	-0.29

Margins

Gross margin is 32.97%, with operating and profit margins of -273.83% and -275.50%.

Gross Margin	32.97%
Operating Margin	-273.83%
Pretax Margin	-278.15%
Profit Margin	-275.50%
EBITDA Margin	-235.78%
EBIT Margin	-273.83%
FCF Margin	n/a

Dividends & Yields

EPA:AFME does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-25.83%
FCF Yield	-20.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4